APA (7th ed.) Citation

Vandenberghe, R., & Gass, A. (2016). Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials. Alzheimer's research & therapy, 8, . https://doi.org/10.1186/s13195-016-0189-7

Chicago Style (17th ed.) Citation

Vandenberghe, Rik, and Achim Gass. "Bapineuzumab for Mild to Moderate Alzheimer’s Disease in Two Global, Randomized, Phase 3 Trials." Alzheimer's Research & Therapy 8 (2016). https://doi.org/10.1186/s13195-016-0189-7.

MLA (9th ed.) Citation

Vandenberghe, Rik, and Achim Gass. "Bapineuzumab for Mild to Moderate Alzheimer’s Disease in Two Global, Randomized, Phase 3 Trials." Alzheimer's Research & Therapy, vol. 8, 2016, https://doi.org/10.1186/s13195-016-0189-7.